Ignite Creation Date:
2025-12-26 @ 11:14 AM
Ignite Modification Date:
2026-03-02 @ 11:14 PM
Study NCT ID:
NCT02004028
Status:
TERMINATED
Last Update Posted:
2024-02-20
First Post:
2013-12-02
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Window of Opportunity Study of VS-6063 (Defactinib) in Surgical Resectable Malignant Pleural Mesothelioma Participants
Sponsor:
Verastem, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
VS-6063-203
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None